Trade Koninklijke Philips Adr - PHGus CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Koninklijke Philips NV ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
| Prev. Close* | 20.56 |
| Open* | 20.6 |
| 1-Year Change* | 8.48% |
| Day's Range* | 20.6 - 20.97 |
| 52 wk Range | 15.63-24.27 |
| Average Volume (10 days) | 798.99K |
| Average Volume (3 months) | 18.91M |
| Market Cap | 21.31B |
| P/E Ratio | -100.00K |
| Shares Outstanding | 915.99M |
| Revenue | 20.15B |
| EPS | -0.76 |
| Dividend (Yield %) | 3.90116 |
| Beta | 0.91 |
| Next Earnings Date | Jan 29, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 22, 2024 | 20.56 | 0.31 | 1.53% | 20.25 | 20.62 | 20.18 |
| Apr 19, 2024 | 19.93 | -0.04 | -0.20% | 19.97 | 20.09 | 19.89 |
| Apr 18, 2024 | 19.93 | -0.05 | -0.25% | 19.98 | 20.09 | 19.88 |
| Apr 17, 2024 | 20.10 | 0.17 | 0.85% | 19.93 | 20.16 | 19.85 |
| Apr 16, 2024 | 20.28 | -0.10 | -0.49% | 20.38 | 20.39 | 20.20 |
| Apr 15, 2024 | 20.36 | -0.24 | -1.17% | 20.60 | 20.66 | 20.28 |
| Apr 12, 2024 | 20.00 | -0.48 | -2.34% | 20.48 | 20.48 | 20.00 |
| Apr 11, 2024 | 20.55 | -0.04 | -0.19% | 20.59 | 20.62 | 20.30 |
| Apr 10, 2024 | 20.37 | -0.17 | -0.83% | 20.54 | 20.60 | 20.25 |
| Apr 9, 2024 | 20.57 | 0.09 | 0.44% | 20.48 | 20.67 | 20.43 |
| Apr 8, 2024 | 20.40 | 0.13 | 0.64% | 20.27 | 20.54 | 20.24 |
| Apr 5, 2024 | 20.02 | 0.00 | 0.00% | 20.02 | 20.14 | 19.97 |
| Apr 4, 2024 | 20.31 | -0.28 | -1.36% | 20.59 | 20.64 | 20.30 |
| Apr 3, 2024 | 20.37 | 0.29 | 1.44% | 20.08 | 20.37 | 20.05 |
| Apr 2, 2024 | 19.86 | -0.08 | -0.40% | 19.94 | 19.99 | 19.83 |
| Apr 1, 2024 | 19.78 | -0.18 | -0.90% | 19.96 | 19.97 | 19.70 |
| Mar 28, 2024 | 19.94 | -0.16 | -0.80% | 20.10 | 20.19 | 19.93 |
| Mar 27, 2024 | 20.27 | 0.19 | 0.95% | 20.08 | 20.35 | 20.08 |
| Mar 26, 2024 | 19.99 | 0.01 | 0.05% | 19.98 | 20.04 | 19.90 |
| Mar 25, 2024 | 19.84 | -0.08 | -0.40% | 19.92 | 20.01 | 19.81 |
Koninklijke Philips Adr Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total revenue | 17827 | 17156 | 17313 | 17147 | 18121 |
| Revenue | 17827 | 17156 | 17313 | 17147 | 18121 |
| Cost of Revenue, Total | 10595 | 9895 | 9320 | 9249 | 9568 |
| Gross Profit | 7232 | 7261 | 7993 | 7898 | 8553 |
| Total Operating Expense | 19356 | 16603 | 16049 | 15781 | 16402 |
| Selling/General/Admin. Expenses, Total | 5280 | 4717 | 4551 | 4711 | 4982 |
| Research & Development | 2103 | 1705 | 1691 | 1790 | 1683 |
| Unusual Expense (Income) | 1389 | 405 | 579 | 25 | 161 |
| Other Operating Expenses, Total | -11 | -119 | -92 | 6 | 8 |
| Operating Income | -1529 | 553 | 1264 | 1366 | 1719 |
| Interest Income (Expense), Net Non-Operating | -154 | -34 | -13 | -72 | -154 |
| Other, Net | -48 | -10 | -40 | -46 | -62 |
| Net Income Before Taxes | -1731 | 509 | 1211 | 1248 | 1503 |
| Net Income After Taxes | -1618 | 612 | 999 | 990 | 1310 |
| Minority Interest | -3 | -4 | -8 | -5 | -7 |
| Net Income Before Extra. Items | -1621 | 608 | 991 | 985 | 1303 |
| Total Extraordinary Items | 13 | 2711 | 196 | 183 | -213 |
| Net Income | -1608 | 3319 | 1187 | 1168 | 1090 |
| Income Available to Common Excl. Extra. Items | -1621 | 608 | 991 | 984 | 1303 |
| Income Available to Common Incl. Extra. Items | -1608 | 3319 | 1187 | 1167 | 1090 |
| Diluted Net Income | -1608 | 3319 | 1187 | 1167 | 1090 |
| Diluted Weighted Average Shares | 920.988 | 950.279 | 957.561 | 972.338 | 954.839 |
| Diluted EPS Excluding Extraordinary Items | -1.76007 | 0.63981 | 1.03492 | 1.01199 | 1.36463 |
| Dividends per Share - Common Stock Primary Issue | 0.69161 | 0.69161 | 0.84042 | 0.80279 | |
| Diluted Normalized EPS | 0.24642 | 1.94148 | 1.82147 | 1.48926 | 1.72884 |
| Total Adjustments to Net Income | -1 |
| Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|
| Total revenue | 4471 | 4470 | 4167 | 5422 | 4310 |
| Revenue | 4471 | 4470 | 4167 | 5422 | 4310 |
| Cost of Revenue, Total | 2538 | 2508 | 2411 | 3201 | 2580 |
| Gross Profit | 1933 | 1962 | 1756 | 2221 | 1730 |
| Total Operating Expense | 4247 | 4249 | 4750 | 5251 | 5839 |
| Selling/General/Admin. Expenses, Total | 1264 | 1269 | 1237 | 1475 | 1329 |
| Research & Development | 445 | 468 | 528 | 503 | 615 |
| Other Operating Expenses, Total | 0 | 4 | 574 | 46 | -16 |
| Operating Income | 224 | 221 | -583 | 171 | -1529 |
| Interest Income (Expense), Net Non-Operating | -95 | -105 | -95 | -164 | 45 |
| Net Income Before Taxes | 130 | 116 | -678 | 7 | -1485 |
| Net Income After Taxes | 98 | 74 | -663 | -113 | -1329 |
| Minority Interest | -2 | -2 | 0 | 0 | -1 |
| Net Income Before Extra. Items | 96 | 72 | -663 | -113 | -1330 |
| Total Extraordinary Items | -7 | 0 | -3 | 8 | 1 |
| Net Income | 89 | 72 | -666 | -105 | -1329 |
| Total Adjustments to Net Income | -1 | 1 | -1 | ||
| Income Available to Common Excl. Extra. Items | 95 | 72 | -662 | -113 | -1331 |
| Income Available to Common Incl. Extra. Items | 88 | 72 | -665 | -105 | -1330 |
| Diluted Net Income | 88 | 72 | -665 | -105 | -1330 |
| Diluted Weighted Average Shares | 940.362 | 946.54 | 881.519 | 889.181 | 885.332 |
| Diluted EPS Excluding Extraordinary Items | 0.10102 | 0.07607 | -0.75098 | -0.12708 | -1.50339 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Diluted Normalized EPS | 0.23089 | 0.18457 | -0.11094 | 0.14778 | -0.30373 |
| Other, Net | 1 | -1 | |||
| Unusual Expense (Income) | 26 | 1331 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Current Assets | 10259 | 10347 | 11227 | 9459 | 9572 |
| Cash and Short Term Investments | 1183 | 2305 | 3226 | 1426 | 2124 |
| Cash & Equivalents | 1172 | 2303 | 3226 | 1425 | 1688 |
| Short Term Investments | 11 | 2 | 0 | 1 | 436 |
| Total Receivables, Net | 4653 | 4288 | 4561 | 5019 | 4458 |
| Accounts Receivable - Trade, Net | 4203 | 3920 | 4220 | 4600 | 4108 |
| Total Inventory | 4049 | 3450 | 2993 | 2773 | 2674 |
| Prepaid Expenses | 174 | 172 | 169 | 188 | 193 |
| Other Current Assets, Total | 200 | 132 | 278 | 53 | 123 |
| Total Assets | 30688 | 30961 | 27713 | 27016 | 26019 |
| Property/Plant/Equipment, Total - Net | 2638 | 2699 | 2682 | 2866 | 1712 |
| Property/Plant/Equipment, Total - Gross | 6247 | 5996 | 5975 | 6118 | 4588 |
| Accumulated Depreciation, Total | -3609 | -3298 | -3292 | -3252 | -2876 |
| Goodwill, Net | 10238 | 10637 | 8014 | 8654 | 8503 |
| Intangibles, Net | 3526 | 3650 | 2997 | 3466 | 3589 |
| Long Term Investments | 1197 | 1056 | 670 | 481 | 604 |
| Note Receivable - Long Term | 279 | 224 | 230 | 178 | 162 |
| Other Long Term Assets, Total | 2551 | 2348 | 1893 | 1912 | 1877 |
| Total Current Liabilities | 7934 | 7450 | 7735 | 6978 | 7943 |
| Accounts Payable | 1968 | 1872 | 2119 | 2089 | 2303 |
| Accrued Expenses | 1954 | 2254 | 2343 | 2300 | 2137 |
| Notes Payable/Short Term Debt | 89 | 47 | 76 | 92 | 76 |
| Current Port. of LT Debt/Capital Leases | 236 | 263 | 284 | 290 | 612 |
| Other Current Liabilities, Total | 3687 | 3014 | 2913 | 2207 | 2815 |
| Total Liabilities | 17439 | 16522 | 15843 | 14419 | 13931 |
| Total Long Term Debt | 7018 | 5735 | 5592 | 4877 | 3239 |
| Long Term Debt | 6166 | 4772 | 4644 | 3768 | 3003 |
| Deferred Income Tax | 91 | 83 | 59 | 143 | 152 |
| Minority Interest | 34 | 36 | 31 | 28 | 29 |
| Other Liabilities, Total | 2362 | 3218 | 2426 | 2393 | 2568 |
| Total Equity | 13249 | 14439 | 11870 | 12597 | 12088 |
| Common Stock | 178 | 177 | 182 | 179 | 185 |
| Additional Paid-In Capital | 5025 | 4646 | 4400 | 3671 | 3487 |
| Retained Earnings (Accumulated Deficit) | 6832 | 9344 | 7828 | 8296 | 8266 |
| Treasury Stock - Common | -275 | -476 | -199 | -201 | -399 |
| Unrealized Gain (Loss) | -376 | -344 | -305 | -303 | -181 |
| Other Equity, Total | 1865 | 1092 | -36 | 955 | 730 |
| Total Liabilities & Shareholders’ Equity | 30688 | 30961 | 27713 | 27016 | 26019 |
| Total Common Shares Outstanding | 920.847 | 870.182 | 905.128 | 909.046 | 932.733 |
| Capital Lease Obligations | 852 | 963 | 948 | 1109 | 236 |
| Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 9686 | 10259 | |||
| Cash and Short Term Investments | 968 | 1183 | |||
| Cash & Equivalents | 960 | 1172 | |||
| Total Receivables, Net | 3866 | 4337 | |||
| Accounts Receivable - Trade, Net | 3622 | 4115 | |||
| Total Inventory | 4095 | 4049 | |||
| Other Current Assets, Total | 757 | 690 | |||
| Total Assets | 29506 | 30688 | |||
| Property/Plant/Equipment, Total - Net | 2519 | 2638 | |||
| Goodwill, Net | 10028 | 10238 | |||
| Intangibles, Net | 3335 | 3526 | |||
| Long Term Investments | 1102 | 1197 | |||
| Note Receivable - Long Term | 273 | 279 | |||
| Other Long Term Assets, Total | 2563 | 2551 | |||
| Total Current Liabilities | 8071 | 7934 | |||
| Accounts Payable | 1646 | 1968 | |||
| Accrued Expenses | 1558 | 1626 | |||
| Notes Payable/Short Term Debt | 0 | 0 | |||
| Current Port. of LT Debt/Capital Leases | 1039 | 931 | |||
| Other Current Liabilities, Total | 3828 | 3409 | |||
| Total Liabilities | 17380 | 17439 | |||
| Total Long Term Debt | 7177 | 7270 | |||
| Long Term Debt | 7177 | 7270 | |||
| Deferred Income Tax | 67 | 91 | |||
| Minority Interest | 34 | 34 | |||
| Other Liabilities, Total | 2031 | 2110 | |||
| Total Equity | 12126 | 13249 | |||
| Common Stock | 186 | 178 | |||
| Additional Paid-In Capital | 5776 | 5025 | |||
| Retained Earnings (Accumulated Deficit) | 5348 | 6832 | |||
| Treasury Stock - Common | -306 | -275 | |||
| Unrealized Gain (Loss) | -370 | -376 | |||
| Other Equity, Total | 1492 | 1865 | |||
| Total Liabilities & Shareholders’ Equity | 29506 | 30688 | |||
| Total Common Shares Outstanding | 920.085 | 920.847 | |||
| Short Term Investments | 8 | 11 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -1605 | 3323 | 1195 | 1173 | 1097 |
| Cash From Operating Activities | -185 | 5032 | 2640 | 1911 | 2427 |
| Cash From Operating Activities | 1602 | 1323 | 1462 | 1343 | 1089 |
| Non-Cash Items | 1313 | 905 | 554 | 443 | 1119 |
| Cash Taxes Paid | 333 | 249 | 390 | 354 | 301 |
| Cash Interest Paid | 205 | 151 | 148 | 171 | 170 |
| Changes in Working Capital | -1495 | -519 | -571 | -1048 | -878 |
| Cash From Investing Activities | -1487 | -3672 | -1267 | -512 | -1486 |
| Capital Expenditures | -806 | -763 | -895 | -951 | -843 |
| Other Investing Cash Flow Items, Total | -681 | -2909 | -372 | 439 | -643 |
| Cash From Financing Activities | 500 | -2347 | 483 | -1660 | -1192 |
| Financing Cash Flow Items | -4 | -1 | -2 | -3 | -3 |
| Total Cash Dividends Paid | -412 | -482 | -1 | -453 | -401 |
| Issuance (Retirement) of Stock, Net | -175 | -1613 | -297 | -1318 | -948 |
| Issuance (Retirement) of Debt, Net | 1091 | -251 | 783 | 114 | 160 |
| Foreign Exchange Effects | 41 | 65 | -55 | -2 | 0 |
| Net Change in Cash | -1131 | -922 | 1801 | -263 | -251 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -1605 | -171 | |||
| Cash From Operating Activities | -185 | -591 | |||
| Cash From Operating Activities | 1602 | 696 | |||
| Non-Cash Items | 1313 | -18 | |||
| Cash Taxes Paid | 333 | 258 | |||
| Cash Interest Paid | 205 | 103 | |||
| Changes in Working Capital | -1495 | -1098 | |||
| Cash From Investing Activities | -1487 | -877 | |||
| Capital Expenditures | -806 | -363 | |||
| Other Investing Cash Flow Items, Total | -681 | -514 | |||
| Cash From Financing Activities | 500 | 349 | |||
| Financing Cash Flow Items | -4 | -1 | |||
| Total Cash Dividends Paid | -412 | -350 | |||
| Issuance (Retirement) of Stock, Net | -175 | -35 | |||
| Issuance (Retirement) of Debt, Net | 1091 | 735 | |||
| Foreign Exchange Effects | 41 | 74 | |||
| Net Change in Cash | -1131 | -1045 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Koninklijke Philips Company profile
About Koninklijke Philips NV (ADR)
Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Koninklijke Philips NV (ADR) revenues decreased 1% to EUR17.16B. Net income before extraordinary items decreased 39% to EUR608M. Revenues reflect Personal Health segment decrease of 37% to EUR3.41B, Connected Care and Health Informatics segment decrease of 17% to EUR4.59B, Other Countries segment decrease of 22% to EUR5.04B, Germany segment decrease of 36% to EUR839M.
Equity composition
Common Stock EUR0.20 Par, 07/11, 2B auth., 972,436,000 o/s., net of Treas. @ $1.01B. Insiders control1%. 4/00, 4-for-1 stock split. Qs 2001 and prior do not reflect U.S. GAAP. FY'01 Qs restated due to chg in acct. method. FY'01 Summ Qs reflect the restatement. FY '03 Qs are reclassified.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
High Tech Campus 5
EINDHOVEN
NOORD-BRABANT 5656 AE
NL
Income Statement
- Annual
- Quarterly
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com